Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Neurotoxin-induced animal model of multiple sclerosis: Molecular mechanism focus

View through CrossRef
Background: Neurotoxins can alter the central nervous system. They induce severe clinical symptoms such as encephalopathy, convulsions, muscle paralysis, and respiratory failure. Hence, the neurotoxin can mimic human central nervous system disorders such as Multiple Sclerosis (MS) to study pathophysiology and drugs of development. Objective: This mini-review compared the neurotoxins for mimicking MS in animal models. Method: This study was a narrative review using the scientific electronic databases Scopus, PubMed, and Google Scholar.  All related articles by keywords animal models, multiple sclerosis, and neurotoxins were collected by YP and BW. All authors contributed to manuscript development. Result: Cuprizone, ethidium bromide, lysolecithin, Myelin Oligodendrocyte Glycoprotein (MOG), and Myelin Essential Protein (MBP) are neurotoxins for MS animal models. Cuprizone is particularly relevant for use in studies addressing toxic mechanisms of the demyelination process and studies of therapeutic interventions. Ethidium bromide causes spinal cord demyelination with distinctive features in the oligodendrocytes and astrocytes. However, it is a carcinogen agent. Lysolecithin is suitable for old animal models because the duration for remyelination is relatively longer than others. MOG and MBP are preferable to resemble MS pathophysiology in humans. Conclusion: MOG and MBP are appropriate for generating animal multiple sclerosis models for further in vivo experiments.
Title: Neurotoxin-induced animal model of multiple sclerosis: Molecular mechanism focus
Description:
Background: Neurotoxins can alter the central nervous system.
They induce severe clinical symptoms such as encephalopathy, convulsions, muscle paralysis, and respiratory failure.
Hence, the neurotoxin can mimic human central nervous system disorders such as Multiple Sclerosis (MS) to study pathophysiology and drugs of development.
Objective: This mini-review compared the neurotoxins for mimicking MS in animal models.
Method: This study was a narrative review using the scientific electronic databases Scopus, PubMed, and Google Scholar.
  All related articles by keywords animal models, multiple sclerosis, and neurotoxins were collected by YP and BW.
All authors contributed to manuscript development.
Result: Cuprizone, ethidium bromide, lysolecithin, Myelin Oligodendrocyte Glycoprotein (MOG), and Myelin Essential Protein (MBP) are neurotoxins for MS animal models.
Cuprizone is particularly relevant for use in studies addressing toxic mechanisms of the demyelination process and studies of therapeutic interventions.
Ethidium bromide causes spinal cord demyelination with distinctive features in the oligodendrocytes and astrocytes.
However, it is a carcinogen agent.
Lysolecithin is suitable for old animal models because the duration for remyelination is relatively longer than others.
MOG and MBP are preferable to resemble MS pathophysiology in humans.
Conclusion: MOG and MBP are appropriate for generating animal multiple sclerosis models for further in vivo experiments.

Related Results

PROGNOSTIC VALUE OF FECAL MARKERS IN THE DIAGNOSIS OF AXIAL SPONDYLOARTHRITIS ASSOCIATED WITH CROHN’S DISEASE
PROGNOSTIC VALUE OF FECAL MARKERS IN THE DIAGNOSIS OF AXIAL SPONDYLOARTHRITIS ASSOCIATED WITH CROHN’S DISEASE
Introduction. Spondyloarthritis is presented by various chronic diseases, including classical axial spondyloarthritis and spondyloarthritis associated with inflammatory bowel disea...
Botulinum Toxin Accessory Proteins: Are They Just an Accessory?
Botulinum Toxin Accessory Proteins: Are They Just an Accessory?
BACKGROUND Botulinum neurotoxins produced by Clostridium botulinum consist of a complex of a core neurotoxin protein and one or more nontoxin accessory proteins. The ac...
Narrative review based on fingolimod therapy in pediatric MS
Narrative review based on fingolimod therapy in pediatric MS
The course of pediatric-onset multiple sclerosis and adult multiple sclerosis shows some clinical differences. The rate of having a second attack after the first clinical event is ...
Mobile apps for multiple sclerosis: a focus on self-management (Preprint)
Mobile apps for multiple sclerosis: a focus on self-management (Preprint)
BACKGROUND The explosion of mobile phone users along with the importance of user’s role in managing their health provides a unique opportunity for mHealth a...
Factors affecting MS patients’ health-related quality of life and measurement challenges in Lebanon and the MENA region
Factors affecting MS patients’ health-related quality of life and measurement challenges in Lebanon and the MENA region
Background In the Middle East and North Africa (MENA) region, few studies explored the quality of life of multiple sclerosis patients and the factors affecting it. Objective The ob...
Impact of histone modifier-induced protection against autoimmune encephalomyelitis on multiple sclerosis treatment
Impact of histone modifier-induced protection against autoimmune encephalomyelitis on multiple sclerosis treatment
Multiple sclerosis is a progressive demyelinating central nervous system disorder with unknown etiology. The condition has heterogeneous presentations, including relapsing-remittin...
Animal welfare in Europe and Iran: policy perspective and society
Animal welfare in Europe and Iran: policy perspective and society
Intensive animal production systems are compromising current animal welfare standards. Societies' growing concerns regarding how animals are raised have resulted in continuous poli...

Back to Top